The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 25, 2025

Filed:

Jan. 31, 2020
Applicant:

Hanmi Pharm. Co., Ltd., Hwaseong-si, KR;

Inventors:

In Hwan Bae, Hwaseong-si, KR;

Won Jeoung Kim, Hwaseong-si, KR;

Ji Sook Kim, Hwaseong-si, KR;

Ji Young Song, Hwaseong-si, KR;

Jae Yul Choi, Hwaseong-si, KR;

Min Jeong Kim, Hwaseong-si, KR;

Jung Soo Nam, Hwaseong-si, KR;

Young Gil Ahn, Hwaseong-si, KR;

Assignee:

HANMI PHARM. CO., LTD., Hwaseong-si, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 487/04 (2006.01); C07D 487/08 (2006.01); C07D 487/10 (2006.01); C07D 491/048 (2006.01); C07D 519/00 (2006.01);
U.S. Cl.
CPC ...
C07D 487/04 (2013.01); C07D 487/08 (2013.01); C07D 487/10 (2013.01); C07D 491/048 (2013.01); C07D 519/00 (2013.01);
Abstract

Provided is a compound selected from a compound of chemical formula 1 having lysine-specific demethylase-1 (LSD1) inhibitory activity, and a tautomer, a stereoisomer, and a solvate thereof, and pharmaceutically acceptable salts of the aforementioned components. The compound is effective in the prevention or treatment of diseases caused by abnormal activation of LSD1. Also disclosed is a composition containing the compound as an active ingredient and its uses in preventing and/or treating diseases caused by abnormal activation of LSD1.


Find Patent Forward Citations

Loading…